Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90,326 | 123,794 | 187,675 | 154,901 | 128,994 |
| Marketable Securities | N/A | N/A | 284,255 | 236,949 | 213,591 |
| Receivables | 269,312 | 248,855 | 234,597 | 204,494 | 188,318 |
| Inventories | 195,019 | 173,303 | 164,318 | 158,034 | 188,833 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 39,829 |
| Other current assets | 124,982 | 108,220 | 101,140 | 91,206 | 62,069 |
| TOTAL | $679,639 | $654,172 | $971,985 | $845,584 | $821,634 |
| Non-Current Assets | |||||
| PPE Net | 533,845 | 437,270 | 379,096 | 357,422 | 333,026 |
| Intangibles | 298,192 | 256,314 | 243,719 | 46,155 | 234,843 |
| Other Non-Current Assets | 320,799 | 189,593 | 118,616 | 281,543 | 85,490 |
| TOTAL | $1,152,836 | $883,177 | $741,431 | $685,120 | $653,359 |
| Total Assets | $1,832,475 | $1,537,349 | $1,713,416 | $1,530,704 | $1,474,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 72,172 | 69,534 | 66,968 | 60,057 | 52,648 |
| Accrued Expenses | 322,938 | 260,683 | 253,418 | 236,131 | 205,530 |
| TOTAL | $725,337 | $770,444 | $1,004,567 | $934,568 | $856,761 |
| Non-Current Liabilities | |||||
| Long Term Debt | 698,910 | 601,348 | 606,075 | 593,110 | 597,085 |
| Deferred Revenues | 41,462 | 41,290 | 29,181 | 27,380 | 25,583 |
| Other Non-Current Liabilities | 148,564 | 84,810 | 95,593 | 38,928 | 28,641 |
| TOTAL | $929,313 | $776,138 | $762,691 | $704,349 | $702,227 |
| Total Liabilities | $1,654,650 | $1,546,582 | $1,767,258 | $1,638,917 | $1,558,988 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,330 | 86,007 | 87,123 | 88,005 | 89,638 |
| Common Shares | 10,571 | 10,509 | 10,428 | 10,334 | 10,258 |
| Retained earnings | 1,595,648 | 1,167,928 | 803,545 | 540,401 | 318,356 |
| Other shareholders' equity | -40,911 | -36,886 | -29,746 | -37,843 | -37,143 |
| TOTAL | $177,825 | $-9,233 | $-53,842 | $-108,213 | $-83,995 |
| Total Liabilities And Equity | $1,832,475 | $1,537,349 | $1,713,416 | $1,530,704 | $1,474,993 |